Jennifer Jarrett
Chief Operating Officer; Director; Director, Director, President and CEO; Director, President and Chief Executive Officer · 6 filings · Latest: Sep 25, 2026
Arcus Biosciences, Inc.
Damora Therapeutics, Inc.
Sagimet Biosciences Inc.
Syndax Pharmaceuticals Inc
Zura Bio Ltd
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DMRA | Jennifer Jarrett | Director, Director, President and CEO | Sep 25, 2026 | Purchase | $20.23 | 12,500 | $252.9K | 512,500 | |
RCUS | JENNIFER JARRETT | — | May 6, 2026 | Proposed Sale | $24.60 | 77,793 | $1.9M | — | |
RCUS | JENNIFER JARRETT | — | Apr 23, 2026 | Proposed Sale | $25.20 | 53,826 | $1.4M | — | |
RCUS | JENNIFER JARRETT | — | Apr 8, 2026 | Proposed Sale | $22.57 | 70,000 | $1.6M | — | |
RCUS | Jennifer Jarrett | — | Dec 16, 2025 | Proposed Sale | $21.90 | 22,000 | $481.8K | — | |
RCUS | Jennifer Jarrett | — | Oct 6, 2025 | Proposed Sale | $13.35 | 100,583 | $1.3M | — |